ReviR Therapeutics (溪砾科技) is an innovative drug research and development company driven by artificial intelligence algorithms and genetic technologies. It focuses on RNA spatial structure calculation and has built the voyageRTMAI platform to develop small molecule drugs targeting RNA to address long-standing unmet clinical needs such as tumors and rare diseases.